Entrada Therapeutics, Inc.
← Back to TRDA Overview

Entrada Therapeutics, Inc. (TRDA)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-3.32

Financial Fundamentals

TRDAQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2020-03-31-1.16
2020-06-30-1.16
2020-09-30-17.61
2020-12-31-14.26
2021-03-31-14.60
2021-06-30-12.47
2021-09-30-11.74
2021-12-31-4.81
2022-03-31-3.56
2022-06-30-4.23
2022-09-30-5.25
2022-12-31-4.76
2023-03-31-17.26
2023-06-30-4.85
2023-09-303.69
2023-12-31-13.01
2024-03-314.91
2024-06-302.22
2024-09-30-11.41
2024-12-31156.05
2025-03-31-5.38
2025-06-30-1.62
2025-09-30-1.37
2025-12-31-2.71
2026-03-31-3.32

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.